follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

DiaVacs Inc. appoints chief medical officer

By

Back to Top Comments Print

Edgewater-based biotechnology company DiaVacs Inc. announced today the appointment of Dr. Orville Kolterman as chief medical officer. Kolterman will assume responsibility for the company's clinical development and medical affairs.

According to the announcement, the proprietary core technologies DiaVacs employs to create its dendritic cell therapies allow the immune system to be "retrained" to halt autoimmune attacks against the body's own tissues.

Write to the Editorial Department at editorial@njbiz.com

advertisement

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top